Clinical trial
Liraglutide Treatment in Obese Infertile PCOS Women
NCT06742710 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Liraglutide Treatment in Obese Infertile PCOS Women
- Lead sponsor
- Peking University Third Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- May 22, 2025
- Completion date
- December 31, 2029
- Enrollment
- 890 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
infertility, obesity, pcos